Calcitonin Gene-Related Peptide Effects on Phenotype and IL-۱۲ Production of Monocyte-Derived Dendritic Cells in Rheumatoid Arthritis Patients

Publish Year: 1389
نوع سند: مقاله ژورنالی
زبان: English
View: 181

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-13-4_001

تاریخ نمایه سازی: 3 آبان 1400

Abstract:

Objective(s) Recent studies on human indicate that the introduction of therapeutic use of tolerogenic dendritic cell (DC) for chronic inflammatory conditions is imminent. For the purpose of defining CGRP potency in tolerogenic DC production, we investigated the phenotype and IL-'۲ production of DCs generated from the monocytes of rheumatoid arthritis (RA) patients in the presence of the calcitonin gene-related peptide (CGRP), as a multifunctional neuropeptide. Materials and Methods DCs were generated from isolated monocytes from four resistant and two early female RA patients using IL- ۴, GM-CSF, and CGRP at concentrations of ۰, ', and '۰۰ nM. Then, the phenotype of neuropeptide-treated or untreated DCs was determined using flow cytometry and the IL-'۲ production was measured by ELISA. Results Our study showed that, on the last day of the culture, at a concentration of ' nM CGRP, the mean fluorescence intensity (MFI) for CD۸۰ increased ('۴.'۳%) and the MFIs for CD۸۳, CD۸۶, and HLA-DR decreased ('۴.۵۷%, ۵.۲۸%, and ۶.۸۸% respectively). Moreover, at '۰۰ nM CGRP concentration, the MFI for CD۸۰ increased (''.'۰%) and the MFIs for CD۸۳, CD۸۶, and HLA-DR decreased (۴.۲۷%, '۸.۶۰%, and '۹.۷۵% respectively). In addition, our results indicated that the mean concentrations of IL-'۲ produced at ۰, ', and '۰۰ nm CGRP concentrations measured '۳.۷۲±۲.۴', ''.۰'±'.۶', and ۷±'.۳۴ pg/ml respectively. Conclusion Decreased CD۸۳, CD۸۶, and HLA-DR expression and reduced IL-'۲ production by CGRP were found in the RA patients' monocyte-derived DCs. CD۸۳ is a well-defined DC activation marker. HLA-DR and CD۸۶ are appropriate molecules for inducing an immune response. IL-'۲ promotes cell-mediated immunity. Therefore we suggest that CGRP may be used as an inducer in the production of tolerogenic DCs.

Authors

Javid Morad Abbasi

Immunology Research Center, BuAli Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Maryam Rastin

Immunology Research Center, BuAli Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Zahra Rezaieyazdi

Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Zahra Mirfeizi

Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Seyed-Mohammad Moazzeni

Department of Immunology, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran

Nafise Tabasi

Immunology Research Center, BuAli Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Azam Brook

Immunology Research Center, BuAli Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Mahmoud Mahmoudi

Immunology Research Center, BuAli Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • ۱.Kavanaugh A. Economic consequences of established rheumatoid arthritis and its ...
  • ۲.Lutzky V, Hannawi S, Thomas R. Cells of the synovium ...
  • ۳.Firestein GS. Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. ...
  • ۴.Panayi GS, Corrigall VM. BiP, an anti-inflammatory ER protein, is ...
  • ۵.Yamaoka K, Tanaka Y. Jak inhibitor; possibility and mechanism as ...
  • ۶.Rossi M,Young JW.Human dendritic cells: potent antigen-presenting cells at the ...
  • ۷.Steinbrink K, Mahnke K, Grabbe S, Enk AH, Jonuleit H. ...
  • ۸.Thomson AW, Robbins PD. Tolerogenic dendritic cells for autoimmune disease ...
  • ۹.Manfred B, Lutz GS. Immature, semi-mature and fully mature dendritic ...
  • ۱۰.Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest ...
  • ۱۱.Taub DD. Neuroendocrine interactions in the immune system. Cell Immunol ...
  • ۱۲.Wang H, Xing L, Li W, Hou L, Guo J, ...
  • ۱۳.Harzenetter, MD, Novotny AR, Gais P, Molina CA, Altmayr F, ...
  • ۱۴.Gomes RN, Castro-Faria-Neto HC, Bozza PT, Soares MB, Shoemaker CB, ...
  • ۱۵.Bracci-Laudiero L, Aloe L, Buanne P, Finn A, Stenfors C, ...
  • ۱۶.Fox FE, Kubin M, Cassin M, Niu Z, Hosoi J, ...
  • ۱۷.Torii H, Hosoi J, Beissert S, Xu S, Fox FE, ...
  • ۱۸.Reyes-Garcia MG, Garcia-Tamayo F. A neurotransmitter system that regulates macrophage ...
  • ۲۰.Seiffert K, Granstein RD. Neuroendocrine regulation of skin dendritic cells. ...
  • ۲۱.Bulloch K,McEwen BS, Nordberg J, Diwa A, Baird S. Selective ...
  • ۲۲.Talme T, Liu Z, Sundqvist KG. The neuropeptide calcitonin gene-related ...
  • ۲۳.Schlomer JJ,Storey BB,Ciornei RT,McGillis JP. Calcitonin gene-related peptide inhibits early ...
  • ۲۴.Foreman JC. Substance P and calcitonin gene-related peptide: effects on ...
  • ۲۵.Springer J, Geppetti P, Fischer A, Groneberg DA. Calcitonin gene-related ...
  • ۲۶.Eysselein VE, Reinshagen M, Patel A, Davis W, Nast C, ...
  • ۲۷.Kroeger I, Erhardt A, Abt D, Fischer M, Biburger M, ...
  • ۲۸.Tang Y, Feng Y, Wang X. Calcitonin gene-related peptide potentiates ...
  • ۲۹.Liu J, Chen M, Wang X. Calcitonin gene-related peptide-enhanced nitric ...
  • ۳۰.Yaraee R,Ebtekar M, Ahmadiani A, Sabahi F. Neuropeptides (SP and ...
  • ۳۱.Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by ...
  • ۳۲.Eskandari F,Webster JI, Sternberg EM. Neural immune pathways and their ...
  • ۳۳.Jara LJ, Navarro C, Medina G, Vera-Lastra O, Blaanco F. ...
  • ۳۴.Ghatta S, Nimmagadda D, Calcitonin gene-related peptide: Understanding its role. ...
  • ۳۵.Nong YH, Titus RG, Ribeiro JM, Remold HG. Peptides encoded ...
  • ۳۶.Cao W, Lee SH, Lu J. CD۸۳ is preformed inside ...
  • ۳۷.Prechtel AT, Steinkasserer A.CD۸۳: an update on functions and prospects ...
  • ۳۸.Sansom DM, Manzotti CN, Zheng Y.What's the difference between CD۸۰ ...
  • ۳۹.Perez N, Karumuthil Melethil S, Li R, Praabhakar BS, Holterman ...
  • ۴۰.Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, ...
  • ۴۱.Salek-Ardakani S, Arens R, Flynn R,Sette A, Schoenbereger SP, Croft ...
  • ۴۲.Suvas S, Singh V, Sahdev S, Vohra H, Agrewala JN. ...
  • ۴۳.Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu ...
  • ۴۴.Capellino S, Straub RH. Neuroendocrine immune pathways in chronic arthritis. ...
  • نمایش کامل مراجع